Q4 2018 Agios Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Agios' Fourth Quarter 2018 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request.
I would now like to turn the call over to Kendra Adams, Senior Director, Investor and Public Relations.
Thank you, Shannon. Good morning, everyone, and welcome to Agios' Fourth Quarter 2018 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com.
With me on the call today are Dr. Jackie Fouse, our Chief Executive Officer, who will review key business updates and milestones for 2019; Dr. Chris Bowden, our Chief Medical Officer, who will provide an update on our clinical development activities; Steve Hoerter, our Chief Commercial Officer, who will provide an update on the launch of TIBSOVO; and Andrew Hirsch, our Chief Financial Officer, who will summarize our fourth quarter and full year 2018 financial results. Dr. Scott Biller
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |